Literature DB >> 444096

Generalized cortical electrodecremental event. Clinical and neurophysiological observations in patients with dystonic seizures.

R G Fariello, J M Doro, F M Forster.   

Abstract

Patients with seizures accompanied by generalized cortical electrodecremental event (CEE) have clusters of clinical spells with tonic, dystonic, or atonic components and involvement of autonomic functions. When electroencephalographically detectable foci are present, they behave in a peculiar way; throughout the entire cluster of seizures focal spiking is reduced in the short interictal periods as well as during each individual seizure with CEE, at which time it is suppressed. Focal firing reappears reinforced at the end of each spell and also at the end of the cluster. These facts suggest that the foci responsible for CEE are deeply located. A complex excitatory-inhibitory feedback probably exists between cortical and subcortical foci. These seizures should be differentiated from similar attacks of nonepileptic or epileptic nature. A correct diagnosis is essential given the different therapeutic implications.

Entities:  

Mesh:

Year:  1979        PMID: 444096     DOI: 10.1001/archneur.1979.00500410063009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Pragmatic and behavioral aspects of computerized tomographic scanning in epileptic patients.

Authors:  F M Forster
Journal:  Pavlov J Biol Sci       Date:  1980 Jul-Sep

Review 2.  Initiation, Propagation, and Termination of Partial (Focal) Seizures.

Authors:  Marco de Curtis; Massimo Avoli
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-01       Impact factor: 6.915

3.  Epileptic seizures in patients with acute catatonic syndrome.

Authors:  A Primavera; A Fonti; P Novello; G Roccatagliata; L Cocito
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

Review 4.  How can we identify ictal and interictal abnormal activity?

Authors:  Robert S Fisher; Helen E Scharfman; Marco deCurtis
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.